| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/07/2013 | CA2496376C Methods of drug delivery using sulphated chitinous polymers |
| 05/07/2013 | CA2486714C Compositions for penis enlargement |
| 05/07/2013 | CA2456184C Expression profile of prostate cancer |
| 05/07/2013 | CA2397030C Methods for treating pancreatic disorders |
| 05/02/2013 | WO2013063286A1 Treatment of patients suffering from cancer |
| 05/02/2013 | WO2013063000A1 Method of treating gastrointestinal stromal tumors |
| 05/02/2013 | WO2013062995A1 Compositions and methods for treating deep partial and full thickness wounds and injuries |
| 05/02/2013 | WO2013060872A1 Anticancer combination therapy |
| 05/02/2013 | WO2013060407A1 Skin lightener in phototherapy |
| 05/02/2013 | US20130110249 Anti-glucosaminidase passive immunization for staphylococcus aureus infections |
| 05/02/2013 | US20130109750 Novel arylamide derivatives having antiandrogenic properties |
| 05/02/2013 | US20130109749 Micheliolide derivatives, medicinal composition, producing method and usage thereof |
| 05/02/2013 | US20130109721 FAAH Inhibitors |
| 05/02/2013 | US20130109717 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 05/02/2013 | US20130109712 Statins for the Prevention or Treatment of Drug Addictions |
| 05/02/2013 | US20130109708 Chemical Compounds |
| 05/02/2013 | US20130109701 Chemical Compounds |
| 05/02/2013 | US20130109699 Tetrahydrocarboline derivative |
| 05/02/2013 | US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein |
| 05/02/2013 | US20130109696 Chemical Compounds |
| 05/02/2013 | US20130109692 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 05/02/2013 | US20130109682 Cyclic ether compounds useful as kinase inhibitors |
| 05/02/2013 | US20130109677 Multicyclic compounds and methods of use thereof |
| 05/02/2013 | US20130109676 Oxadiazole Diaryl Compounds |
| 05/02/2013 | US20130109674 Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions |
| 05/02/2013 | US20130109662 Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias |
| 05/02/2013 | US20130109661 Imidazopyridazine compounds |
| 05/02/2013 | US20130109660 Novel pyrimidinecarboxamide derivatives |
| 05/02/2013 | US20130109657 C7-Fluoro Substituted Tetracycline Compounds |
| 05/02/2013 | US20130109654 Anti-cytomegalovirus activity of artemisinin-derived dimers |
| 05/02/2013 | US20130109629 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 05/02/2013 | US20130109628 Microrna compositions and methods related thereto |
| 05/02/2013 | US20130109620 Balaglitazone compositions and methods |
| 05/02/2013 | US20130109617 Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| 05/02/2013 | US20130108693 Dual Controlled Release Dosage Form |
| 05/02/2013 | US20130108684 Hemostatic composition, apparatus, and methods |
| 05/02/2013 | US20130108683 Compositions and methods for treating partial and full thickness wounds and injuries |
| 05/02/2013 | US20130108675 Organic compounds |
| 05/02/2013 | US20130108660 Anti-trypanosome therapeutic and diagnostic applications |
| 05/02/2013 | US20130108646 Optimized degenerative muscle disease diagnostics and treatments |
| 05/02/2013 | US20130108644 Inhibition of AXL Signaling in Anti-Metastatic Therapy |
| 05/02/2013 | US20130108630 Amino acyl trna synthetases for modulating inflammation |
| 05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
| 05/02/2013 | US20130108583 Methods of use for cyclopamine analogs |
| 05/02/2013 | US20130108573 Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| 05/02/2013 | US20130108563 Compositions comprising at least one aqueous phase and at least one fatty phase which comprises avermectin compounds |
| 05/02/2013 | US20130108547 Recombinantly Produced Antibodies Targeting ErbB Signaling Molecules and Methods of Use Thereof for the Diagnosis and Treatment of Disease |
| 05/02/2013 | DE102011117364A1 Hautaufheller in der Phototherapie Skin whitening in phototherapy |
| 05/02/2013 | CA2853095A1 Method of treating gastrointestinal stromal tumors |
| 05/01/2013 | EP2586796A1 Compositions and methods for use for antibodies against sclerostin |
| 05/01/2013 | EP2586794A2 Manufacture, Compositions and Uses of Coagulationfactor VIIA Modulator |
| 05/01/2013 | EP2586462A1 Prophylactic or ameliorating agent for genetic diseases |
| 05/01/2013 | EP2586441A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 05/01/2013 | EP2586439A1 Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
| 05/01/2013 | EP2585161A1 Medical device for self-administration of patients with acute coronary events |
| 05/01/2013 | EP2585114A2 Therapeutic conjugates of a dextrin polymer and an antimicrobial peptide |
| 05/01/2013 | EP2585112A1 Collagen-binding synthetic peptidoglycans for use in vascular intervention |
| 05/01/2013 | EP2585109A2 Compositions and methods for preventing and treating organ injury and/or dysfunction |
| 05/01/2013 | EP2585072A1 Niacin mimetics, and methods of use thereof |
| 05/01/2013 | EP2585062A1 Injectable formulation of a macrocyclic lactone and levamisole |
| 05/01/2013 | EP2585055A1 Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes |
| 05/01/2013 | EP2584899A1 Niacin mimetics, and methods of use thereof |
| 05/01/2013 | EP2584897A1 Resveratrol-containing compositions and methods of use |
| 05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |
| 05/01/2013 | CN103079595A Aqueous composition for ophthalmic administration |
| 05/01/2013 | CN103079575A Laxative containing polyethylene glycol and electrolytes |
| 05/01/2013 | CN103079551A Combination of HDAC inhibitors with thrombocytopenia drugs |
| 05/01/2013 | CN103071154A Combination anticoagulant therapy with a compound that acts as a factor XA inhibitor |
| 05/01/2013 | CN103070907A Medicine resistant to poultry coccidiosis and preparation method thereof |
| 05/01/2013 | CN103070854A Fused cyclic compounds |
| 05/01/2013 | CN103070844A Locating quick-release biological adhesive and application thereof |
| 05/01/2013 | CN103070838A Solid dosage form comprising solid dispersion and method for producing the same |
| 05/01/2013 | CN102302780B Pharmaceutical composition for treating bronchial asthma |
| 05/01/2013 | CN101455644B Long-acting composite contraception microspheres and preparation method thereof |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431613 Memory fixation accelerator |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431550 Denatured soybean product; topical applying |
| 04/30/2013 | US8431354 Bacterial pheromones and uses therefor |
| 04/30/2013 | US8431154 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | CA2514921C Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension |
| 04/30/2013 | CA2417495C Methods for treating cell proliferative disorders and viral infections |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2365742C Formulations for amylin agonist peptides |
| 04/25/2013 | WO2013059791A2 Methods and compositions for promoting axon regeneration and nerve function |
| 04/25/2013 | WO2013059638A1 Combination treatment (eg. with abt-072 or abt -333) of daas for use in treating hcv |
| 04/25/2013 | WO2013058294A1 Therapeutic agent for pancreatic cancer and/or biliary tract cancer |
| 04/25/2013 | WO2013016297A3 Tumor selective chemokine modulation |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130102640 Method for the preparation of cis-1,2-diols in the kilogram scale |
| 04/25/2013 | US20130102615 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| 04/25/2013 | US20130102608 Bipyridyl derivatives |
| 04/25/2013 | US20130102594 Pharmaceutical Formulation of Valsartan |
| 04/25/2013 | US20130102575 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof |
| 04/25/2013 | US20130102569 Methods and Compositions for Preventing or Treating Age-Related Diseases |
| 04/25/2013 | US20130102555 Method of treating diabetes |
| 04/25/2013 | US20130102553 Therapeutic Strategies For Prevention And Treatment Of Alzheimer's Disease |
| 04/25/2013 | US20130102527 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |